William Newell has over 20 years of senior management experience in the biotechnology industry. He joined Sutro Biopharma as CEO in January 2009. Previously, he served as the President of Aerovance, Inc., a venture-backed company developing clinical assets for respiratory diseases. He is also a Board member on BIO’s Emerging Companies Section and Health Section and Chairman of the Board and a member of the Executive Committee of the California Life Sciences Association.